These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 22981249)

  • 1. Testing the risk of bias tool showed low reliability between individual reviewers and across consensus assessments of reviewer pairs.
    Hartling L; Hamm MP; Milne A; Vandermeer B; Santaguida PL; Ansari M; Tsertsvadze A; Hempel S; Shekelle P; Dryden DM
    J Clin Epidemiol; 2013 Sep; 66(9):973-81. PubMed ID: 22981249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor reliability between Cochrane reviewers and blinded external reviewers when applying the Cochrane risk of bias tool in physical therapy trials.
    Armijo-Olivo S; Ospina M; da Costa BR; Egger M; Saltaji H; Fuentes J; Ha C; Cummings GG
    PLoS One; 2014; 9(5):e96920. PubMed ID: 24824199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disagreements in risk of bias assessment for randomized controlled trials in hypertension-related Cochrane reviews.
    Yao Y; Shen J; Luo J; Li N; Liao X; Zhang Y
    Trials; 2024 Jun; 25(1):405. PubMed ID: 38907276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can trial quality be reliably assessed from published reports of cancer trials: evaluation of risk of bias assessments in systematic reviews.
    Vale CL; Tierney JF; Burdett S
    BMJ; 2013 Apr; 346():f1798. PubMed ID: 23610376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of standardized training on the reliability of the Cochrane risk of bias assessment tool: a prospective study.
    da Costa BR; Beckett B; Diaz A; Resta NM; Johnston BC; Egger M; Jüni P; Armijo-Olivo S
    Syst Rev; 2017 Mar; 6(1):44. PubMed ID: 28253938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing machine and human reviewers to evaluate the risk of bias in randomized controlled trials.
    Armijo-Olivo S; Craig R; Campbell S
    Res Synth Methods; 2020 May; 11(3):484-493. PubMed ID: 32065732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Bias in Systematic Reviews of Non-Randomized Studies of Adverse Cardiovascular Effects of Thiazolidinediones and Cyclooxygenase-2 Inhibitors: Application of a New Cochrane Risk of Bias Tool.
    Bilandzic A; Fitzpatrick T; Rosella L; Henry D
    PLoS Med; 2016 Apr; 13(4):e1001987. PubMed ID: 27046153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability of 3 assessment tools used to evaluate randomized controlled trials for treatment of neck pain.
    Graham N; Haines T; Goldsmith CH; Gross A; Burnie S; Shahzad U; Talovikova E
    Spine (Phila Pa 1976); 2012 Mar; 37(6):515-22. PubMed ID: 21673624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of standardized training on the reliability of the Cochrane risk of bias assessment tool: a study protocol.
    da Costa BR; Resta NM; Beckett B; Israel-Stahre N; Diaz A; Johnston BC; Egger M; Jüni P; Armijo-Olivo S
    Syst Rev; 2014 Dec; 3():144. PubMed ID: 25495124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inter-rater reliability and validity of risk of bias instrument for non-randomized studies of exposures: a study protocol.
    Jeyaraman MM; Al-Yousif N; Robson RC; Copstein L; Balijepalli C; Hofer K; Fazeli MS; Ansari MT; Tricco AC; Rabbani R; Abou-Setta AM
    Syst Rev; 2020 Feb; 9(1):32. PubMed ID: 32051035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The revised Cochrane risk of bias tool for randomized trials (RoB 2) showed low interrater reliability and challenges in its application.
    Minozzi S; Cinquini M; Gianola S; Gonzalez-Lorenzo M; Banzi R
    J Clin Epidemiol; 2020 Oct; 126():37-44. PubMed ID: 32562833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new risk of bias checklist applicable to randomized trials, observational studies, and systematic reviews was developed and validated to be used for systematic reviews focusing on drug adverse events.
    Faillie JL; Ferrer P; Gouverneur A; Driot D; Berkemeyer S; Vidal X; Martínez-Zapata MJ; Huerta C; Castells X; Rottenkolber M; Schmiedl S; Sabaté M; Ballarín E; Ibáñez L
    J Clin Epidemiol; 2017 Jun; 86():168-175. PubMed ID: 28487158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inter-review agreement of risk-of-bias judgments varied in Cochrane reviews.
    Könsgen N; Barcot O; Heß S; Puljak L; Goossen K; Rombey T; Pieper D
    J Clin Epidemiol; 2020 Apr; 120():25-32. PubMed ID: 31866473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agreement in Risk of Bias Assessment Between RobotReviewer and Human Reviewers: An Evaluation Study on Randomised Controlled Trials in Nursing-Related Cochrane Reviews.
    Hirt J; Meichlinger J; Schumacher P; Mueller G
    J Nurs Scholarsh; 2021 Mar; 53(2):246-254. PubMed ID: 33555110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methodologically rigorous risk of bias tools for nonrandomized studies had low reliability and high evaluator burden.
    Jeyaraman MM; Rabbani R; Copstein L; Robson RC; Al-Yousif N; Pollock M; Xia J; Balijepalli C; Hofer K; Mansour S; Fazeli MS; Ansari MT; Tricco AC; Abou-Setta AM
    J Clin Epidemiol; 2020 Dec; 128():140-147. PubMed ID: 32987166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the reliability, usability, and applicability of AMSTAR, AMSTAR 2, and ROBIS: protocol for a descriptive analytic study.
    Gates A; Gates M; Duarte G; Cary M; Becker M; Prediger B; Vandermeer B; Fernandes RM; Pieper D; Hartling L
    Syst Rev; 2018 Jun; 7(1):85. PubMed ID: 29898777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inter-rater reliability and concurrent validity of ROBINS-I: protocol for a cross-sectional study.
    Jeyaraman MM; Rabbani R; Al-Yousif N; Robson RC; Copstein L; Xia J; Pollock M; Mansour S; Ansari MT; Tricco AC; Abou-Setta AM
    Syst Rev; 2020 Jan; 9(1):12. PubMed ID: 31931871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practicalities of using a modified version of the Cochrane Collaboration risk of bias tool for randomised and non-randomised study designs applied in a health technology assessment setting.
    Robertson C; Ramsay C; Gurung T; Mowatt G; Pickard R; Sharma P;
    Res Synth Methods; 2014 Sep; 5(3):200-11. PubMed ID: 26052846
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.